News
- - News
Entertainment
- - Funny & Gags
  - Gossip
Business
- - Business
Sports
- - Sports
Science & Tech
- - Tech
  - Science

Aurobindo Pharma gains 2% on USFDA approval for anti-HIV drug

News / News 7 years ago 558 Views comments

The triple combination product is expected to be launched in sub-Saharan Africa in Q3FY18.

Source:
Moneycontrol Latest News

facebook
twitter
Whatsapp
google+
linkedin
email

Paid Prime Membership on Primevideo.com

Previous post

Buy Bharat Financial, Eicher Motors; sell Fortis Health, MCX India: Mitessh Thakkar

Next post

Banks stare at union strike on Tuesday, services may be hit

Comments

Related Posts

How Gujarat voted: Trends in BJP and Congress's vote-share since 2002

News / News - 6 years ago

Shailja Comm#39;s AGM held on September 12, 2017

News / News - 7 years ago

'PM Modi made a revolutionary law': Triple talaq petitioner who joined BJP

News / News - 6 years ago

SVP Global#39;s AGM held on September 28, 2017

News / News - 7 years ago

Deadline for selling pre-GST goods extended to Dec 31

News / News - 7 years ago

RBIâs likely rate cut: 25 bps is neither here nor there, stay put or go for 50

News / News - 7 years ago

RIVER Collection launch: Latest styles from your favourite designers | Made for Amazon | Up to 20% off - Launching on 1st

Follow @truearacom

TrueAra

Pages

Popular Tweets
Privacy
Terms Of Use

Categories

Living
Movies

Follow us

Copyright 2016-2017 Content Aggregator All rights reserved.

No results found.

Home
News
- News
Entertainment
- Funny & Gags
- Gossip
Business
- Business
Sports
- Sports
Science & Tech
- Tech
- Science